Literature DB >> 15012704

Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients.

Wai H Lim1, Timothy H Mathew, John E Cooper, Scott Bowden, Graeme R Russ.   

Abstract

Polyomavirus BK viral allograft nephropathy is a potentially reversible cause of deteriorating function of kidney allografts. Initial treatment involves reducing immunosuppressive medications, with low-dose cidofovir an effective alternative in refractory cases. We describe two cases of BK viral allograft nephropathy responding to low-dose cidofovir after a reduction in immunosuppressive medications failed to clear the virus or stabilize the deterioration in renal function. There were no significant side-effects from this treatment in either patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15012704     DOI: 10.1111/j.1440-1797.2008.00214.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  3 in total

Review 1.  Polyomavirus-associated nephropathy.

Authors:  Cristina Costa; Rossana Cavallo
Journal:  World J Transplant       Date:  2012-12-24

2.  Alkoxylalkyl Esters of Nucleotide Analogs Inhibit Polyomavirus DNA Replication and Large T Antigen Activities.

Authors:  Nichodemus O Onwubiko; Suraya A Diaz; Marcela Krečmerová; Heinz Peter Nasheuer
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

3.  Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains.

Authors:  Ilya Lebeau; Graciela Andrei; Marcela Krecmerová; Erik De Clercq; Antonin Holy; Robert Snoeck
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.